Blood Glucose Testing Market Scope
Blood glucose testing is the procedure that is used to measure the concentration of glucose in the blood. Blood glucose testing can be carried out anywhere at home using a blood glucose meter. Basically glucose is a simple sugar which is considered as one of the main sources of energy. The human body converts the carbohydrates whatever they eat into glucose. There are different types of tests to check diabetes, where diabetes can cause because of the rise in the level of glucose in the body. I few cases the test happens with the use of hypoglycemia.
The market study is being classified by Type (Fingertip Testing and Alternate Site Testing), by Application (Self/Home Care and Hospital & Clinics) and major geographies with country level break-up.
The global blood glucose testing market is highly competitive and consists of some key players. In terms of market share, few of the key players presently dominate the global market. These market players are leveraging on strategic collaborative creativities to intensification their market share and escalation their profitability. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Blood Glucose Testing market throughout the predicted period.
American Diabetes Association (United States), Menarini Diagnostics (Italy), Abaxis (United States), Abbott Laboratories (United States), ACON Laboratories, Inc. (United States), AgaMatrix (Germany), Bayer (Germany), Bio-Rad (United States), Roche (Switzerland) and LifeScan (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Ascensia (Switzerland), Medtronic (Ireland), Dexcom (United States), Ypsomed (Switzerland) and B. Braun (Germany).
AdvanceMarketAnalytics has segmented the market of Global Blood Glucose Testing market by Type, Application and Region.
On the basis of geography, the market of Blood Glucose Testing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
- High adoption in United States regions because of the increasing number of diabetes patients
- Technology advancement in glucose monitoring devices
- Growing Prevalence of Diabetes
- Increasing Number of Product Launches
- Pipeline Products and Ongoing Research - There is technology advancement in products and continuous investment by the leading players. With the increasing number of healthcare centers and laboratories across the developed regions.
- High Cost and Poor Reimbursement associated with Blood Glucose Monitoring Systems and its product Supplies
- Invasiveness of Blood Glucose Monitors
Key Target AudienceVenture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Blood Glucose Testing Service Providers, Raw Material Suppliers, Government Regulatory and Research Organizations and End-Use Industries
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase